Trial Profile
Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Calcineurin inhibitors
- Indications Liver transplant rejection
- Focus Biomarker; Pharmacodynamics
- 28 Dec 2009 New trial record